Serum Institute of India | The Business Standard
Skip to main content
  • Home
  • Economy
    • Aviation
    • Banking
    • Bazaar
    • Budget
    • Industry
    • NBR
    • RMG
    • Corporates
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Features
    • Book Review
    • Brands
    • Earth
    • Explorer
    • Food
    • Habitat
    • In Focus
    • Luxury
    • Mode
    • Panorama
    • Pursuit
    • Wheels
  • Epaper
    • GOVT. Ad
  • More
    • Subscribe
    • Videos
    • TBS Graduates
    • Thoughts
    • Splash
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • COVID-19
    • Long Read
    • Interviews
    • Offbeat
    • Tech
    • Magazine
  • বাংলা
The Business Standard

Tuesday
December 05, 2023

Sign In
Subscribe
  • Home
  • Economy
    • Aviation
    • Banking
    • Bazaar
    • Budget
    • Industry
    • NBR
    • RMG
    • Corporates
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Features
    • Book Review
    • Brands
    • Earth
    • Explorer
    • Food
    • Habitat
    • In Focus
    • Luxury
    • Mode
    • Panorama
    • Pursuit
    • Wheels
  • Epaper
    • GOVT. Ad
  • More
    • Subscribe
    • Videos
    • TBS Graduates
    • Thoughts
    • Splash
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • COVID-19
    • Long Read
    • Interviews
    • Offbeat
    • Tech
    • Magazine
  • বাংলা
TUESDAY, DECEMBER 05, 2023

Serum Institute of India

Photo :UNB
Global Economy

Indian vaccine giant Serum plans African plant in global expansion

Photo :UNB
Coronavirus chronicle

India's Serum Institute applies for full approval of Covishield vaccine

The Serum Institute was founded by Adar Poonawalla's father Cyrus Poonawalla in 1966 Photo: Reuters
Coronavirus chronicle

'Hope to launch Covavax for adults in October, in early 2022 for kids': Adar Poonwalla

A vial of AstraZeneca coronavirus disease (Covid-19) vaccine doses at a facility in Milton, Ontario, Canada, March 3, 2021. REUTERS/Carlos Osorio
Coronavirus chronicle

Covishield okayed by 7 EU Nations, Switzerland, Iceland

Employees operate a filling machine inside a lab at the Serum Institute of India, in Pune, India, November 30, 2020. Picture taken November 30, 2020. REUTERS/Francis Mascarenhas/Files
Coronavirus chronicle

SII plans to start clinical trials of Novavax for children in July

A nurse displays a vial of Covishield, the Covid-19 vaccine being manufactured by the Serum Institute of India, at a medical centre in Mumbai. (File Photo)
Coronavirus chronicle

Can manufacture, supply 90-100 million Covishield doses in June: SII to govt

File photo
Bangladesh

'Attempts underway to collect Oxford vaccine from other countries'

A Serum technician checks on coronavirus vaccine production. Photo: Bloomberg 
Panorama

Adar Poonawalla: Rise of the Vaccine Prince

The Serum Institute was founded by Adar Poonawalla's father Cyrus Poonawalla in 1966 Photo: Reuters
Coronavirus chronicle

Vaccine prince exposes India’s best and worst

Photo: NDTV
Coronavirus chronicle

India's Serum Institute plans to start vaccine production outside India

FILE PHOTO: A man walks past a signpost of India's Serum Institute, the world's largest maker of vaccines, which is developing a vaccine against the coronavirus disease (Covid-19) at its laboratory in Pune, India, May 18, 2020. REUTERS/Euan Rocha
Coronavirus chronicle

SII to raise output to 100 mln AstraZeneca doses by July, not end-May

The White House is pictured shortly after sunrise in Washington/Reuters
Coronavirus chronicle

WH uncertain over lifting curbs on vaccine raw materials export to India

FILE PHOTO: A woman speaks inside a waiting zone area at a health clinic where COVID-19 vaccination is being given to healthcare workers in Kolkata, India, February 1, 2021. REUTERS/Rupak De Chowdhuri/File Photo
Coronavirus chronicle

India reports Covid-19 vaccine shortage as second wave surges record highs

  • Show More
EMAIL US
contact@tbsnews.net
FOLLOW US
WHATSAPP
+880 1847416158
The Business Standard
  • About Us
  • Contact us
  • Sitemap
  • Privacy Policy
  • Comment Policy
Copyright © 2023
The Business Standard All rights reserved
Technical Partner: RSI Lab

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - oped.tbs@gmail.com

For advertisement- sales@tbsnews.net